1-4 of 4
Esther Schachter-Tokarz
Close
Sort by
Journal Articles

Treatment-influenced associations of PML-RAR α mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia

Robert E. Gallagher, Barry K. Moser, Janis Racevskis, Xavier Poiré, Clara D. Bloomfield, Andrew J. Carroll, Rhett P. Ketterling, Diane Roulston, Esther Schachter-Tokarz, Da-cheng Zhou, I-Ming L. Chen, Richard Harvey, Greg Koval, Dorie A. Sher, James H. Feusner, Martin S. Tallman, Richard A. Larson, Bayard L. Powell, Frederick R. Appelbaum, Elisabeth Paietta, Cheryl L. Willman, Wendy Stock
Journal: Blood
Blood (2012) 120 (10): 2098–2108.
https://doi.org/10.1182/blood-2012-01-407601
Published: 2012
Includes: Supplemental data
Journal Articles

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710.

Robert E. Gallagher, MD, Barry K. Moser, PhD, Janis Racevskis, Xavier Poiré, MD, Clara D. Bloomfield, MD, Andrew J. Carroll, PhD, Rhett Ketterling, Diane Ralston, Esther Schachter-Tokarz, Dacheng Zhou, MD, PhD, I-Ming L. Chen, DVM, MS, Richard Harvey, Greg Koval, MS, Dorie A Sher, BS, James H. Feusner, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, Richard A. Larson, MD, Bayard L. Powell, MD, Elisabeth Paietta, PhD, Cheryl L. Willman, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 1038.
https://doi.org/10.1182/blood.V116.21.1038.1038
Published: 2010
Journal Articles

Uncommon Mutations in PML-RARα Associated with Poor Outcome after First Relapse in APL.

Esther Schachter-Tokarz, BS, Bruno Cassinat, MD, Charikleia Kelaidi, MD, Christine Chomienne, MD,PhD, Claude Gardin, MD, Emmanuel Raffoux, MD, Herve Dombret, MD, Pierre Fenaux, MD, Robert Gallagher, MD
Journal: Blood
Blood (2007) 110 (11): 4248.
https://doi.org/10.1182/blood.V110.11.4248.4248
Published: 2007
Journal Articles

Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.

Wendy Stock, MD, Richard Harvey, MD, Barry Moser, PhD, Dorie Sher, BS, Esther Schachter-Tokarz, BS, Matthew Myers, BS, James Slack, MD, Bayard Powell, MD, Clara D. Bloomfield, MD, Richard A. Larson, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, James Feusner, MD, Cheryl Willman, MD, Robert Gallagher, MD
Journal: Blood
Blood (2006) 108 (11): 494.
https://doi.org/10.1182/blood.V108.11.494.494
Published: 2006